Christoph Scheid

Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in Adult Patients With Acute Lymphoblastic Leukemia: No Difference in Related Compared With Unrelated Transplant in First Complete Remission

Michael Kiehl, L. Kraut, Rainer Schwerdtfeger et al. · Journal of Clinical Oncology · 2004 · 204 citations · Full text

Medicine, Hematology, Oncology +17

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 185 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Christoph Scheid, P. Sonneveld, Ingo Schmidt‐Wolf et al. · Haematologica · 2013 · 127 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis

Matthias Stelljes, Utz Krug, Dietrich W. Beelen et al. · Journal of Clinical Oncology · 2013 · 107 citations · Full text

Medicine, Oncology, Chemotherapy +12

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial

Maximilian Merz, Hans Salwender, Mathias Haenel et al. · Haematologica · 2015 · 71 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15